Teva Pharmaceuticals (NASDAQ: TEVA) is one of the few pharmaceuticals that struck when the time was right when Lipitor expired. Pfizer's (NYSE: PFE) drug brought in approximately $7.8 billion, and revenues are almost guaranteed to decline significantly...